Inactivated rabies virus vaccine

ApprovedVaccine

Sanofi

Inactivated rabies virus vaccine is one of 90 biologic programs targeting Poliomyelitis. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

PoliomyelitisActive, not recruiting

HepatitisActive, not recruiting

InfluenzaActive, not recruiting

FibromyalgiaActive, not recruiting

PoliomyelitisPhase 2

Active, not recruiting

HepatitisApproved

Active, not recruiting

InfluenzaPhase 3

Active, not recruiting

FibromyalgiaPreclinical

Active, not recruiting

Competition

Competitive Landscape

1053 competitors in Influenza

#DrugCompanyPhaseTrials

Inactivated rabies virus vaccine

Sanofi

Approved

7 2

Fluzone

Sanofi

Preclinical

16 3

Fluzone

GSK

Preclinical

37 4

Crestor

AstraZeneca

Preclinical

1 5

Avigan

AAppili Therapeutics Inc.

Preclinical

6 6

COMIRNATY

Pfizer

Preclinical

1 7

Antihistamine

Arrowhead Pharmaceuticals

Preclinical

1 8

PD-1/PD-L1 Inhibitors

CChuangzhen Chen

Preclinical

1 9

Fluvirin

Novartis

Preclinical

3 10

Afluria

NNational Heart, Lung, and Blood Institute (NHLBI)

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Influenza7 trials

Lot-to-Lot Consistency Study of the Investigational, Inactivated, Split-Virion Influenza Vaccine in Adults

Completed· Sanofi logo

Sanofi·Phase 3·NCT00383539·2,256 enrolled

Immunogenicity of Two Dosages of Inactivated, Split-Virion Influenza Vaccine Given by an Alternate Route in the Elderly

Completed· Sanofi logo

Sanofi·Phase 2·NCT00296829·1,080 enrolled

Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Elderly

Completed· Sanofi logo

Sanofi·Phase 3·NCT00391053·3,851 enrolled

Show 4 more trials

Immunogenicity Study of the Influenza Vaccine in Adults

Completed· Sanofi logo

Sanofi·Phase 2·NCT00258934·978 enrolled

Study of Immune Response in Adults and Elderly Subjects Vaccinated With Inactivated Influenza Vaccines

Completed· Sanofi logo

Sanofi·Phase 2·NCT00776438·160 enrolled

Study of Inactivated, Split-Virion Influenza Vaccine Compared With the Reference Vaccine Vaxigrip® in the Elderly

Completed· Sanofi logo

Sanofi·Phase 3·NCT00383526·3,707 enrolled

Study of Inactivated, Split-Virion Influenza Vaccine Administered by Intradermal Route Versus Vaxigrip® in Adults

Completed· Sanofi logo

Sanofi·Phase 2·NCT00703651·1,150 enrolled

Poliomyelitis5 trials

A Study to Evaluate the Safety and Immunogenicity of Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) in Healthy Adults

Completed· CanSino Biologics Inc. logo

CanSino Biologics Inc.·Phase 1·NCT06101173·72 enrolled

The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains

Completed·CChinese Academy of Medical Sciences·Phase 1·NCT01048190·130 enrolled

The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains(Sabin IPV)

Completed·IInstitute of Medical Biology, Chinese Academy of Medical Sciences·Phase 3·NCT01510366·1,200 enrolled

Show 2 more trials

The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains (IPV)

Completed·CChinese Academy of Medical Sciences·Phase 2·NCT01056705·500 enrolled

A Clinical Study to Evaluate the Safety and Immunogenicity of Inactivated Poliomyelitis Vaccine in Healthy Infants

Completed·LLG Chem·Phase 2/3·NCT03169725·1,417 enrolled

Immunogenicity3 trials

Immunogenicity and Safety of a Fractional Booster Dose of IPV Intradermally Versus Full Dose Intramuscularly

Completed· Sanofi logo

Sanofi·Phase 2·NCT00885157·225 enrolled

Immunogenicity and Safety of Fractional Doses of IPV Intradermally vs Full Doses Intramuscularly

Completed· Sanofi logo

Sanofi·Phase 2·NCT00604058·236 enrolled

Comparative Study of Immunogenicity and Safety of Flu-ID Vaccine Versus Flu-IM Vaccine

Completed· Sanofi logo

Sanofi·Phase 3·NCT00554333·795 enrolled

Children1 trial

Safety of Imovax Polio in Chinese Infants and Children

Completed· Sanofi logo

Sanofi·Phase 3·NCT00258843·40 enrolled

Fibromyalgia1 trial

Influenza Vaccination in Fibromyalgia Patients

Unknown status·TTel-Aviv Sourasky Medical Center·N/A·NCT01465477·80 enrolled

4 more indications

Pediatric1 trial

Study of DTwP-HepB-Hib-IPV (SHAN6™) Vaccine Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in Thailand

Completed· Sanofi logo

Sanofi·Phase 3·NCT04429295·460 enrolled

Vaccine1 trial

Inactivated Poliovirus Vaccine (IPV) With or Without E.Coli Double Mutant Heat-Labile Toxin (dmLT) Challenge Study in Healthy Adults

Completed·PPATH·Phase 1·NCT04232943·87 enrolled

Hepatitis1 trial

Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined Vaccine

Completed· Sanofi logo

Sanofi·Phase 4·NCT00313950·470 enrolled

Efficacy and Safety1 trial

Efficacy and Safety of Dengue Vaccine in Healthy Children

Completed· Sanofi logo

Sanofi·Phase 2·NCT00842530·4,002 enrolled

Sources

References

[1]
ClinicalTrials.gov — 21 trial records for Inactivated rabies virus vaccine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Inactivated rabies virus vaccine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Inactivated rabies virus vaccine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Sanofi company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Vaccine[2]
Highest Phase: Approved[1]
Company: Sanofi

Inactivated rabies virus vaccine

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Influenza7 trials

Poliomyelitis5 trials

Immunogenicity3 trials

Children1 trial

Fibromyalgia1 trial

Pediatric1 trial

Vaccine1 trial

Hepatitis1 trial

Efficacy and Safety1 trial

References

Drug Info

Quick Facts

Related News